SCHEMBL9664125

SCHEMBL9664125

OCc1ccc2c(c1)ncn2-c1ccco1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 9/20 0.44
▸ RAB9A P51151 9/20 0.44
▸ SMN1; SMN2 Q16637 6/20 0.44
▸ ALDH1A1 P00352 6/20 0.44
▸ HPGD P15428 5/20 0.44
▸ TP53 P04637 3/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ MAPT P10636 3/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ FGFR1 P11362 6/20 0.41
▸ POLB P06746 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ SRC P12931 1/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ SHMT2 P34897 1/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9662842 0.78 FGFR1 (0.38) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL7989531 0.77 FGFR1 (0.65) FGFR1SRCHTT
SCHEMBL29602591 0.76 HTT (0.55) HPGDHSD17B10FGFR1POLBHTT
SCHEMBL23680876 0.71 FGFR1 (0.63) ALDH1A1HPGDFGFR1
SCHEMBL9663546 0.71 TP53 (0.51) SMN1; SMN2HPGDTP53FGFR1SRC
SCHEMBL2648767 0.71 MEN1 (0.48) HPGDFGFR1SRC
SCHEMBL2653370 0.70 NT5E (0.44) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL2653551 0.70 FGFR1 (0.46) HPGDFGFR1SRC
SCHEMBL2642029 0.70 FGFR1 (0.52) FGFR1SRCHTT
SCHEMBL2654510 0.70 GABRA1 (0.40) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0260744-B1 (1H-IMIDAZOL-1-YLMETHYL) SUBSTITUTED BENZIMIDAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1992-12-16 — — EP disclosed
US-4859684-A (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives and use thereof in treating androgen dependent disorders JANSSEN PHARMACEUTICA N.V. (BE) 1989-08-22 — — US disclosed
EP-0260744-A2 (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1988-03-23 — — EP disclosed
Send feedback